title: Applying Atherosclerotic Risk Prevention Guidelines to Elderly Patients: A Bridge Too Far?
abstract: The primary prevention of atherosclerotic disease is on the basis of optimal management of the major risk factors. For the major risk factors of diabetes, hypertension, and dyslipidemia, management for most patients is on the basis of well developed and extensive evidence-based diagnostic and therapeutic guidelines. However, for a growing segment of the population who are at the highest risk for atherosclerotic disease (ie, older adults), the application of these guidelines is problematic. First, few studies that form the evidence base for these primary prevention guidelines actually include substantial numbers of elderly subjects. Second, elderly patients represent a special population from multiple perspectives related to their accumulation of health deficits and in their development of frailty. These patients with frailty and multiple comorbidities have been mostly excluded from the primary prevention studies upon which the guidelines are based yet comprise a very significant proportion of the very elderly population. Third, elderly people are at most risk from adverse drug reactions because of the increasing number of medications prescribed in this patient population. When applying the existing guidelines to elderly people the limitations of our knowledge must be recognized regarding how best to mitigate the high risk of heart disease in our aging population and how to generalize these recommendations to the management of the largest subgroup of elderly patients (ie, those with multiple comorbidities and frail older adults).
authors.affiliation: Discipline of Medicine, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada. Electronic address: ross.feldman@med.mun.ca.
authors.forename: Ross D
authors.initials: RD
authors.lastname: Feldman
authors.affiliation: Western Centers for Public Health and Family Medicine, Western University, London, Ontario, Canada.
authors.forename: Stewart B
authors.initials: SB
authors.lastname: Harris
authors.affiliation: Department of Medicine and Robarts Research Institute, Western University, London, Ontario, Canada.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Hegele
authors.affiliation: Department of Medicine and Robarts Research Institute, Western University, London, Ontario, Canada.
authors.forename: J Geoffrey
authors.initials: JG
authors.lastname: Pickering
authors.affiliation: Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
authors.forename: Kenneth
authors.initials: K
authors.lastname: Rockwood
mesh_terms: D000368:Aged; D000375:Aging; D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control*; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D011307:Drug Prescriptions; D050171:Dyslipidemias / Q000150:complications; D017408:Guidelines as Topic; D006801:Humans; D006973:Hypertension / Q000150:complications; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods; D012307:Risk Factors